{"id":770698,"title":"Characteristics and clinical outcomes of nirmatrelvir/ritonavir recipients in Canada - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T02:32:17.566000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2023-49/issue-10-october-2023/characteristics-clinical-outcomes-n-r-recipients-canada.html","snippet":"Characteristics and clinical outcomes of nirmatrelvir/ritonavir recipients in Canada Download this article as a PDF Published by: The Public Health Agency of Canada Issue: Volume 49-10, October 2023: Influenza and Other Respiratory Infections Date published: October 2023 ISSN:…","rawSnapshotUrl":"/api/snapshots/raw/770698","browseUrl":"https://replay.healtharchive.ca/job-7/20260306023217/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2023-49/issue-10-october-2023/characteristics-clinical-outcomes-n-r-recipients-canada.html#ha_snapshot=770698","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}